Digital therapeutics for remote symptom monitoring and management in cancer care: the current and future state

E Basch¹

Affiliations

Free article

Editorial

E Basch. Ann Oncol. 2023 Aug.

Free article

. 2023 Aug;34(8):635-637.

doi: 10.1016/j.annonc.2023.06.003.

E Basch¹

¹ Division of Oncology, University of North Carolina, Chapel Hill, USA. Electronic address: ebasch@med.UNC.edu.

No abstract available

Comment on

Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2- metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial.
Harbeck N, Fasching PA, Wuerstlein R, Degenhardt T, Lüftner D, Kates RE, Schumacher J, Räth P, Hoffmann O, Lorenz R, Decker T, Reinisch M, Göhler T, Staib P, Gluz O, Schinköthe T, Schmidt M; AGO-B WSG PreCycle investigators (see Appendix 1). Harbeck N, et al. Ann Oncol. 2023 Aug;34(8):660-669. doi: 10.1016/j.annonc.2023.05.003. Epub 2023 May 16. Ann Oncol. 2023. PMID: 37201751 Clinical Trial.